Nasal Vaccine

Glenmark Pharmaceuticals Ltd on Monday said its arm Glenmark Specialty SA has received approval from China's National Medical Products Administration for the nasal spray RYALTRIS used to treat allergic rhinitis. The National Medical Products Administration (NMPA) of China has approved RYALTRIS Compound Nasal Spray (GSP 301 NS) for the treatment of allergic rhinitis (AR) in adults and children -- specifically for treatment of moderate to severe seasonal AR in adults and pediatric patients 6 years of age and older, and moderate to severe perennial AR in adults and pediatric patients 12 years of age and older, the company said in a statement. The approval granted with zero supplementation requests is an important milestone in Glenmark's respiratory pipeline and reflects continued progress in advancing innovative and differentiated therapies for patients with chronic conditions, it added. "The approval of RYALTRIS in China is a significant step in expanding our specialty respiratory ...

The funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA)

The government has approved Bharat Biotech's intranasal Covid-19 vaccine, iNCOVACC (BBV154), as a booster dose for those above 18 years of age. How does this needle-free vaccine work and how different is it from the existing ones? To get the answers, Business Standard spoke to Dr Gagandeep Kang, virologist and professor at the Christian Medical College, Vellore. Watch the video for more

The Indian nasal vaccine cannot be given to those who have allready taken a precaution or booster dose, the head of the country's vaccine task force said

The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries

Its local production ramp-up remains unhurried as demand for boosters reduces

iNCOVACC first intranasal Covid shot to receive approval for primary 2-dose schedule, heterologous booster us

The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country

How can India make its cars safer? Should India consider raising the retirement age? Are auto ancillaries a favourable bet as commodity costs ease? How do nasal vaccines work? Answers here

The Drugs Controller General of India has approved the first intra-nasal Covid-19 vaccine for restricted use. A few drops in both the nostril will keep the virus at bay. Let us find out more

Besides Bharat Biotech's nasal vaccine, India has 13 vaccines to fight against Covid-19. Two have been approved for manufacturing, while 11 have been approved for emergency use

Glenmark had conducted the study on 306 vaccinated and unvaccinated adults with symptomatic mild Covid-19 disease across 20 clinical trial sites in India

A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours

The firm, which has tasted success with its oral antiviral drug favipiravir, is now betting on the NONS to drive revenues from its Covid-19 portfolio

The idea is to see which combination induces better and long-lasting immune response

A top government official said that if this vaccine works it can be a game changer in the fight against COVID-19

Scientists have developed a vaccine against Covid-19 that can be given in one dose via the nose, and is effective in preventing infection in mice susceptible to the novel coronavirus

The nasal spray has not been recommended for those who are immune compromised, pregnant women or nursing mothers